These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 21330466)

  • 1. Neurotrophic tyrosine kinase receptor B/neurotrophin 4 signaling axis is perturbed in clinical and experimental pulmonary fibrosis.
    Avcuoglu S; Wygrecka M; Marsh LM; Günther A; Seeger W; Weissmann N; Fink L; Morty RE; Kwapiszewska G
    Am J Respir Cell Mol Biol; 2011 Oct; 45(4):768-80. PubMed ID: 21330466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen.
    Ponticos M; Holmes AM; Shi-wen X; Leoni P; Khan K; Rajkumar VS; Hoyles RK; Bou-Gharios G; Black CM; Denton CP; Abraham DJ; Leask A; Lindahl GE
    Arthritis Rheum; 2009 Jul; 60(7):2142-55. PubMed ID: 19565505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylase inhibitor restores surfactant protein-C expression in alveolar-epithelial type II cells and attenuates bleomycin-induced pulmonary fibrosis in vivo.
    Ota C; Yamada M; Fujino N; Motohashi H; Tando Y; Takei Y; Suzuki T; Takahashi T; Kamata S; Makiguchi T; Yamaya M; Kubo H
    Exp Lung Res; 2015; 41(8):422-34. PubMed ID: 26151196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sunitinib, a Small-Molecule Kinase Inhibitor, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice.
    Huang X; Wang W; Yuan H; Sun J; Li L; Wu X; Luo J; Gu Y
    Tohoku J Exp Med; 2016 Aug; 239(4):251-61. PubMed ID: 27439438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased pulmonary neurotrophin protein expression in idiopathic interstitial pneumonias.
    Ricci A; Graziano P; Bronzetti E; Saltini C; Sciacchitano S; Cherubini E; Renzoni E; Du Bois RM; Grutters JC; Mariotta S
    Sarcoidosis Vasc Diffuse Lung Dis; 2007 Mar; 24(1):13-23. PubMed ID: 18069415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of prosurvival signaling in fibroblasts by a protein kinase inhibitor protects against fibrotic tissue injury.
    Vittal R; Horowitz JC; Moore BB; Zhang H; Martinez FJ; Toews GB; Standiford TJ; Thannickal VJ
    Am J Pathol; 2005 Feb; 166(2):367-75. PubMed ID: 15681821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibitory effect of ginsan on TGF-β mediated fibrotic process.
    Ahn JY; Kim MH; Lim MJ; Park S; Lee SL; Yun YS; Song JY
    J Cell Physiol; 2011 May; 226(5):1241-7. PubMed ID: 20945375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
    Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
    PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The angiotensin II receptor 2 is expressed and mediates angiotensin II signaling in lung fibrosis.
    Königshoff M; Wilhelm A; Jahn A; Sedding D; Amarie OV; Eul B; Seeger W; Fink L; Günther A; Eickelberg O; Rose F
    Am J Respir Cell Mol Biol; 2007 Dec; 37(6):640-50. PubMed ID: 17630322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis.
    Wang XM; Zhang Y; Kim HP; Zhou Z; Feghali-Bostwick CA; Liu F; Ifedigbo E; Xu X; Oury TD; Kaminski N; Choi AM
    J Exp Med; 2006 Dec; 203(13):2895-906. PubMed ID: 17178917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosyltransferases and glycosaminoglycans in bleomycin and transforming growth factor-β1-induced pulmonary fibrosis.
    Venkatesan N; Tsuchiya K; Kolb M; Farkas L; Bourhim M; Ouzzine M; Ludwig MS
    Am J Respir Cell Mol Biol; 2014 Mar; 50(3):583-94. PubMed ID: 24127863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis.
    Zhang L; Li Y; Liang C; Yang W
    Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of epithelial-mesenchymal transition (EMT) and fibroblast function in cerium oxide nanoparticles-induced lung fibrosis.
    Ma J; Bishoff B; Mercer RR; Barger M; Schwegler-Berry D; Castranova V
    Toxicol Appl Pharmacol; 2017 May; 323():16-25. PubMed ID: 28315692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MEK inhibition suppresses the development of lung fibrosis in the bleomycin model.
    Galuppo M; Esposito E; Mazzon E; Di Paola R; Paterniti I; Impellizzeri D; Cuzzocrea S
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Jul; 384(1):21-37. PubMed ID: 21533992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis.
    Tsoyi K; Liang X; De Rossi G; Ryter SW; Xiong K; Chu SG; Liu X; Ith B; Celada LJ; Romero F; Robertson MJ; Esposito AJ; Poli S; El-Chemaly S; Perrella MA; Shi Y; Whiteford J; Rosas IO
    Am J Respir Crit Care Med; 2021 Aug; 204(3):312-325. PubMed ID: 33784491
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of the ERK1/2-ubiquitous calpains pathway attenuates experimental pulmonary fibrosis in vivo and in vitro.
    Zou M; Zhang G; Zou J; Liu Y; Liu B; Hu X; Cheng Z
    Exp Cell Res; 2020 Jun; 391(1):111886. PubMed ID: 32017927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spleen tyrosine kinase (Syk) inhibitor fostamatinib limits tissue damage and fibrosis in a bleomycin-induced scleroderma mouse model.
    Pamuk ON; Can G; Ayvaz S; Karaca T; Pamuk GE; Demirtas S; Tsokos GC
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S15-22. PubMed ID: 26148346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protease-activated receptors (PAR)-1 and -3 drive epithelial-mesenchymal transition of alveolar epithelial cells - potential role in lung fibrosis.
    Wygrecka M; Didiasova M; Berscheid S; Piskulak K; Taborski B; Zakrzewicz D; Kwapiszewska G; Preissner KT; Markart P
    Thromb Haemost; 2013 Aug; 110(2):295-307. PubMed ID: 23739922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis.
    Wollin L; Maillet I; Quesniaux V; Holweg A; Ryffel B
    J Pharmacol Exp Ther; 2014 May; 349(2):209-20. PubMed ID: 24556663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Wnt/β-catenin signaling suppresses bleomycin-induced pulmonary fibrosis by attenuating the expression of TGF-β1 and FGF-2.
    Chen X; Shi C; Meng X; Zhang K; Li X; Wang C; Xiang Z; Hu K; Han X
    Exp Mol Pathol; 2016 Aug; 101(1):22-30. PubMed ID: 27112840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.